Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions

NCT07278609 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT07278609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07278609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Observational
Overall status
Recruiting
Start date
October 29, 2025
Completion date
June 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory arthritis, muskuloskeletal diseases, rheumatic diseases, systemic autoimmune diseases, systemic lupus erthematosus (sle), vasculitis